FLORA VASSILIOS KONTOPIDOU

Dr. FLORA VASSILIOS KONTOPIDOU


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2025 in Information
Verified
Journal Article
Open access
PDF file
Christos KokkotisChristos Kokkotis
Christos Kokkotis
SMSerafeim Moustakidis
Serafeim Moustakidis
SSStefan James Swift
Stefan James Swift
FLORA VASSILIOS KONTOPIDOUFLORA VASSILIOS KONTOPIDOU
FLORA VASSILIOS KONTOPIDOU
IKIoannis A. Kavouras
Ioannis A. Kavouras
SGStamatios Giannoukos
Stamatios Giannoukos
Breath analysis is a non-invasive diagnostic method that offers insights into both physiological and pathological conditions. Exhaled breath contains volatile organic compounds, which act as biomarkers for disease detection, allowing for the monitoring of treatments and the tailoring of medicine to individuals. Recent advancements in chemical sensing, mass spectrometry, and spectroscopy have improved the ability to identify these biomarkers; however, traditional statistical approaches often struggle to handle the complexities of breath data. Artificial intelligence (AI) and machine learning (ML) have revolutionized breath analysis by uncovering intricate patterns among volatile breath markers, enhancing diagnostic precision, and facilitating real-time disease identification. Despite significant progress, challenges remain, including issues with data standardization, model interpretability, and the necessity for extensive and varied datasets. This study reviews the applications of ML in analyzing breath volatile organic compounds, highlighting methodological shortcomings and obstacles to clinical validation. A thorough literature review was performed using the PubMed and Scopus databases, which included studies that focused specifically on the role of machine learning in disease diagnosis and incidence prediction via breath analysis. Among the 524 articles reviewed, 97 satisfied the specified inclusion criteria. The selected studies applied ML techniques, fell within the scope of this review, and emphasize the potential of ML models for non-invasive diagnostics. The findings indicate that traditional ML methods dominate, while ensemble methods are on the rise, and deep learning (DL) techniques (especially CNNs and LSTMs) are increasingly used for classifying respiratory diseases. Techniques for feature selection (such as PCA and ML-based methods) were frequently implemented, though challenges related to explainability and data standardization persist. Future studies should focus on enhancing model transparency and developing methods to further integrate AI into the clinical setting to facilitate early disease detection and advance precision medicine.

5 June 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
FLORA VASSILIOS KONTOPIDOUFLORA VASSILIOS KONTOPIDOU
FLORA VASSILIOS KONTOPIDOU
MAMaria Antonopoulou
Maria Antonopoulou
AVANASTASIA VOTSI
ANASTASIA VOTSI
VPVassiliki Papoutsaki
Vassiliki Papoutsaki
VBVassiliki Bereri
Vassiliki Bereri
GDGeorge Daikos
George Daikos
Background/Objectives: Candidozyma auris (C. auris) is a multidrug-resistant pathogen recognized as a serious global public health threat. Herein, we report a C. auris outbreak that was successfully contained in a general hospital located in Athens, Greece. Methods: This study was conducted between December 2021 and December 2023. Upon identification of the first imported case of C. auris, the following infection control measures were applied in a stepwise approach: the promotion of hand hygiene, contact precautions and isolation, chlorhexidine gluconate bathing of patients, enhanced environmental cleaning, and active surveillance cultures of all high-risk patients upon admission. Active surveillance cultures were performed weekly in non-colonized ICU patients. Results: A total of 1564 screening samples from 890 patients were analyzed. Sixty-three patients were identified to be colonized and three to be infected with C. auris. After implementing screening and enhanced environmental cleaning, the quarterly incidence of hospital-acquired cases decreased from 0.37 to 0.04 cases per 1000 patient-days (slope of linear trend: −0.08; 95% CI: −0.16 to −0.0004; p = 0.05), despite the continuous inflow of already colonized patients. Conclusions: A bundle of infection control measures, including active surveillance cultures upon admission and enhanced environmental cleaning, can contain C. auris dissemination in acute healthcare settings.